Diabetic Ketoacidosis Clinical Trials

Find Diabetic Ketoacidosis Clinical Trials Near You

Feasibility and Effectiveness of Tele-diabetes Remote System on Glycemic Control and Quality of Life of Children and Youth With Type 1 Diabetes

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to examine the feasibility and effectiveness of a tele-diabetes remote monitoring system on managing type 1 diabetes (T1DM) among children and adolescents. The study aims to assess whether this system, which incorporates a WhatsApp-based alert system, can improve clinical outcomes, increase adherence to treatment, enhance quality of life, and reduce healthcare utilization in this population. The main questions it aims to answer are: Does the tele-diabetes remote system improve glycemic control (e.g., time in range \[TIR\], frequency of hypoglycemia and hyperglycemia, HbA1c levels)? Does it enhance adherence to treatment and overall quality of life for children and youth with T1DM? Does the system reduce the number of emergency room visits for diabetic ketoacidosis (DKA) or severe hypoglycemia, hospitalizations, and overall medical costs? Researchers will compare participants who receive WhatsApp notifications (intervention group) with those receiving standard care (control group) to evaluate differences in clinical outcomes, quality of life, and healthcare burden. Participants will: Receive notifications via WhatsApp messages sent by a system developed by the research team, which monitors glucose trends in real-time and sends alerts when patterns (e.g., hypoglycemia, hyperglycemia) are detected. Participate in follow-ups supported by the hybrid medical team between routine clinic visits.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Maximum Age: 25
Healthy Volunteers: f
View:

• Participants must have a confirmed diagnosis of Type 1 Diabetes Mellitus (T1DM).

• Participants must use Dexcome Continuous Glucose Monitoring (CGM)

• Must have access to a smartphone capable of receiving WhatsApp messages.

• Participants must use a closed-loop insulin pump system (also known as an artificial pancreas system) omnipod DIY or Tandem.

Locations
Other Locations
Israel
Sheba medical center
RECRUITING
Ramat Gan
Contact Information
Primary
Noah Gruber, MD
noah.gruber@sheba.health.gov.il
+97235305015
Time Frame
Start Date: 2026-08-25
Estimated Completion Date: 2027-05-30
Participants
Target number of participants: 100
Treatments
Experimental: intervention
trends (e.g., hyperglycemia, hypoglycemia) and send automated WhatsApp alerts
No_intervention: Control
Participants in this arm will continue with standard care for managing Type 1 Diabetes
Sponsors
Leads: Sheba Medical Center

This content was sourced from clinicaltrials.gov